THOUSAND OAKS, Calif. Biotech drugmaker Amgen Inc. said a federal court has enforced a preliminary injunction barring Roche from launching an anemia drug that would compete against its products. Amgen makes the anemia drugs Epogen and Aranesp, which are blockbuster products used to control red blood cell levels in...
[read full story]